pharmacokinetic interactions

Related by string. pharmacokinetic interaction * Pharmacokinetics . Pharmacokinetic . pharmacokinetics : pharmacokinetics PK . pharmacokinetic PK . safety tolerability pharmacokinetics . favorable pharmacokinetic profile / Interactions . InterAction . INTERACTION : Customer Interaction Solutions . reader interaction discussion . Insight Engagement Interaction * *

Related by context. Frequent words. (Click for all words.) 73 renal toxicity 73 hepatotoxicity 72 antidiabetic 72 Dasatinib 72 fulvestrant 71 antiangiogenic 71 antiemetic 71 cardiac toxicity 71 mycophenolate mofetil 70 Pioglitazone 70 bleomycin 70 voriconazole 69 Cyclosporine 69 pheochromocytoma 69 Bortezomib 69 nicotinic acid 69 vasodilators 69 calcineurin inhibitors 69 immunomodulatory 69 antithrombotic 69 decitabine 69 Erlotinib 69 Topiramate 69 ziprasidone 68 amphotericin B 68 nelfinavir 68 nucleoside 68 systemic toxicity 68 Voreloxin 68 LY# [002] 68 LY# [003] 68 anticonvulsants 68 INTELENCE 68 PREZISTA r 68 Anti TNF 68 leflunomide 68 tipranavir 68 ketoconazole 68 Natalizumab 68 QT prolongation 68 hypercalcemia 68 intravenously administered 67 #ME# 67 NNRTIs 67 Olanzapine 67 Navelbine 67 proteasome inhibitors 67 Epratuzumab 67 BAY #-# 67 GSK# [001] 67 Irinotecan 67 olmesartan 67 selegiline 67 verapamil 67 TNF α 67 liposomal formulation 67 raltegravir 67 Traficet EN 67 partial agonist 67 Lenalidomide 67 granisetron 67 glitazones 67 pegylated 67 pharmacodynamic effects 67 Zolinza 67 DOXIL 67 bicalutamide 67 fumarate 67 cyclosporin 67 antiepileptic 67 neuroleptics 67 phenytoin 66 antiproliferative 66 enfuvirtide 66 glatiramer acetate 66 elotuzumab 66 ISTODAX 66 DAVANAT 66 interferon alfa 66 xenograft models 66 orally bioavailable 66 pharmacokinetic properties 66 alpha blocker 66 INTEGRILIN 66 anti mitotic 66 PEG SN# 66 Combination therapy 66 N methyl 66 baclofen 66 imipramine 66 nosocomial pneumonia 66 sulfasalazine 66 Aurora kinase 66 thrombolytics 66 enalapril 66 Doxorubicin 66 nucleoside analogue 66 tolvaptan 66 neuroprotective properties 66 Bevacizumab 66 CCX#

Back to home page